Advertisement

Effects of MGB on Type 2 Diabetes in Lower BMI Patients

  • Tarek Mahdy
  • Waleed Gado
Chapter

Abstract

The Mini-gastric bypass (MGB) has resulted in significant weight loss and resolution of type 2 diabetes (T2D). The current indication for bariatric surgery is mainly for patients with BMI >35 with co-morbidities. However, success is being reported with MGB for T2D with BMI <35. Evidence suggests that bypass of the duodenum may provide superiority of MGB over sleeve gastrectomy (SG) and even over Roux-en-Y gastric bypass (RYGB) for T2D remission. MGB and RYGB have similar mechanisms of T2D remission, but being easier to perform, MGB may be the superior option.

MGB is being found to provide good long-term control of T2D with BMI <35, and earlier intervention appears to yield better results. Due to its low complication rate, MGB may be considered for T2D patients even with class I obesity. However, it appears that the lower the BMI, the less responsive T2D is to bariatric surgery. However, the resolution after MGB and OAGB has shown durable results, including after BMI <35.

Keywords

MGB Type 2 diabetes (T2D) BMI <35 GLP-1 Incretins OAGB Metabolic surgery Bariatric surgery 

References

  1. 1.
    IDF Diabetes ATLAS, 5th ed. http://www.idf.org/diabetesatlas/. Accessed 23 Jun 2017.
  2. 2.
    National Diabetes Fact Sheet. Center for Disease Control. https://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed 4 Jul 2017.
  3. 3.
    Diabetes Control and Complications Trial. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–83.CrossRefGoogle Scholar
  4. 4.
    UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRefGoogle Scholar
  5. 5.
    Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000;23:1499–504.CrossRefPubMedGoogle Scholar
  6. 6.
    Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med. 2004;117:762–74.CrossRefPubMedGoogle Scholar
  7. 7.
    Mason EE. The mechanisms of surgical treatment of type 2 diabetes. Obes Surg. 2005;15:459–61.CrossRefPubMedGoogle Scholar
  8. 8.
    Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995;222:339–52.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gumbs AA, Modlin IM, Ballantyne GH. Change in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.CrossRefPubMedGoogle Scholar
  10. 10.
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.CrossRefPubMedGoogle Scholar
  11. 11.
    Kim MJ, Hur KY. Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m2) patients. Obes Surg. 2014;24:1044–51.CrossRefPubMedGoogle Scholar
  12. 12.
    Kular KS, Machandra N, Chema GK. Seven years of mini-gastric bypass in type II diabetes patients with a body mass index <35 kg/m2. Obes Surg. 2016;26:1457–62.CrossRefPubMedGoogle Scholar
  13. 13.
    Cohen R, Pinheiro JS, Correa JL, Schiavon C. Laparoscopic roux-en-Y gastric bypass for BMI <35 kg/m2: a tailored approach. Surg Obes Relat Dis. 2006;2:401–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg. 2005;15:751–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for treatment of diabetes patients: a multi-institutional international study. J Gastrointest Surg. 2012;16:45–52.CrossRefPubMedGoogle Scholar
  16. 16.
    Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-en-Y gastric bypass and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26:926–32.CrossRefPubMedGoogle Scholar
  17. 17.
    Quan Y, Huang A, Ye M, et al. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015;2015:152852.  https://doi.org/10.1155/2015/152852.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Jammu GS, Sharma R. An eight-year experience with 189 type 2 diabetic patients after mini-gastric bypass. Integr Obes Diabetes. 2016;2(4):246–9.  https://doi.org/10.15761/IOD.1000154.CrossRefGoogle Scholar
  19. 19.
    Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;8:628–42.CrossRefGoogle Scholar
  20. 20.
    Friedman MN, Sancetta AJ, Magovern GJ. The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet. 1955;100:201–4.PubMedGoogle Scholar
  21. 21.
    Bosello O, Armellini F, Pelloso M, et al. Glucose tolerance in jejunoileal bypass for morbid obesity: a fifteen month follow-up. Diabetes Metab. 1978;43:159–62.Google Scholar
  22. 22.
    Ackerman NB. Observations on the improvements in carbohydrate metabolism in diabetic and other morbidly obese patients after jejunoileal bypass. Surg Gynecol Obstet. 1981;152:581–6.PubMedGoogle Scholar
  23. 23.
    Halverson JD, Kramer J, Cave A, et al. Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery. 1982;92:235–40.PubMedGoogle Scholar
  24. 24.
    Herbst CA, Hughes TA, Gwynne JT, et al. Gastric bariatric operation in insulin-treated adults. Surgery. 1984;95:209–13.PubMedGoogle Scholar
  25. 25.
    Scopinaro N, Gianetta E, Friedman D, et al. Evolution of biliopancreatic bypass. Clin Nutr. 1986;5(Suppl):137–46.Google Scholar
  26. 26.
    Pories WJ, Caro JF, Flickinger EG, et al. The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville gastric bypass. Ann Surg. 1987;206:316–23.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Pories WJ, MacDonald KG Jr, Flickinger EG, et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg. 1992;215:633–42.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Boza C, Munoz R, Salinas J, et al. Safety and efficacy of roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg. 2011;21:1330–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index of 35 kg/m2. Diabetes Obes Metab. 2012;14:262–70.CrossRefPubMedGoogle Scholar
  30. 30.
    Reis CEG, Alvarez-Leite JI, Bressan J, Alfenas RC. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14:365–72.CrossRefPubMedGoogle Scholar
  31. 31.
    Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC. Effect of laparoscopic mini-gastric bypass for type 2 dabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.CrossRefPubMedGoogle Scholar
  32. 32.
    Shimizu H, Timratana P, Schauer PR, et al. Review of metabolic surgery for type 2 diabetes in patients with a BMI <35 kg/m2. J Obes. 2012;2012:9.CrossRefGoogle Scholar
  33. 33.
    Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 3-year outcomes. N Engl J Med. 2014;370:2002–13.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Kelley DE, Wing R, Buonocore C, et al. Relative effects of caloric restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1993;77:1287–93.PubMedGoogle Scholar
  35. 35.
    Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: normalization of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–14.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Patti ME, Houten SM, Bianco A, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17:1671–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Fetner R, McGinty J, Russell C, et al. Incretins, diabetes, and bariatric surgery: a review. Surg Obes Relat Dis. 2005;1:589–98.CrossRefPubMedGoogle Scholar
  38. 38.
    Laferrere B, McGinty J, Heshka S, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007;30:1709–16.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Lee WJ, Chong K, Lin YH, Wei JH, Chen SC. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24:1552–62.CrossRefPubMedGoogle Scholar
  40. 40.
    Deitel M. Letter to the Editor: Bariatric Surgery Worldwide 2013 reveals a rise in mini-gastric bypass. Obes Surg. 2015;25:2165.CrossRefPubMedGoogle Scholar
  41. 41.
    Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses – first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.CrossRefPubMedGoogle Scholar
  42. 42.
    Bruzzi M, Rau C, Voron T, Guenzi M, Berger A, Chevallier JM. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11:321–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Georgiadou D, Sergentanis TN, Nixon A, Diamantis T, Tsigris C, Psaltopoulou T. Efficacy and safety of laparoscopic mini-gastric bypass. A systematic review. Surg Obes Relat Dis. 2014;10:984–91.CrossRefPubMedGoogle Scholar
  44. 44.
    Deitel M, Hargroder D, Peraglie C. Mini-gastric bypass for bariatric surgery increasing worldwide. Austin J Surg. 2016;3(3):1092–6.  https://doi.org/10.26420/austinjsurg.2016.1092.CrossRefGoogle Scholar
  45. 45.
    Garcia-Caballero M, Valle M, Martinez-Moreno JM, Miralles F, Toval JA, Mata JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27:623–31.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21:794–6.CrossRefGoogle Scholar
  47. 47.
    Zimmet P, Turner R, McCarty D, Rowley M, Mackay I. Crucial points at diagnosis: type 2 diabetes or slow type 1 diabetes. Diabetes Care. 1999;22(Suppl 2):B59–64.PubMedGoogle Scholar
  48. 48.
    Deitel M. Slow-progression, autoimmune, type 1 diabetes in adults: a cause of failure of resolution of diabetes after bariatric surgery. Surg Obes Relat Dis. 2009;5:705–6.CrossRefPubMedGoogle Scholar
  49. 49.
    Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Higa K, Ho T, Tercero F, Yunus T, Boone KB. Laparoscopic roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7:516–25.CrossRefPubMedGoogle Scholar
  51. 51.
    Milone M, Di Minno MN, Leongito M, Maietta P, Bianco P, Taffuri C, et al. Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol. 2013;19:6590–7.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Musella M, Apers J, Rheinwalt K, Ribeiro R, Manno E, Greco F, et al. Efficacy of bariatric surgery in type 2 diabetes mellitus remission: the role of mini gastric bypass/one anastomosis gastric bypass and sleeve gastrectomy at 1 year of follow-up. A European survey. Obes Surg. 2016;26:933–40.CrossRefPubMedGoogle Scholar
  53. 53.
    Carbajo MA, Jimenez JM, Castro MJ, Ortiz-Solorzano J, Arango A. Outcomes and weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European Accreditation Council for Excellence Centers for Bariatric Surgery with Laparoscopic One Anastomosis Gastric Bypass. Nutr Hosp. 2014;30:1032–8.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Tarek Mahdy
    • 1
  • Waleed Gado
    • 1
  1. 1.Faculty of MedicineMansoura UniversityMansouraEgypt

Personalised recommendations